Industry Articles
Updates about sleep-related diagnostic devices, therapies, products and companies
The AASM has created a gold standard of sleep records to validate third party automated sleep scoring algorithms for the Autoscoring Certification: Sleep Stage Pilot Program. The goal of this project is to establish objective performance requirements for third party automated sleep scoring algorithms [...]
The modern sleep disorders center is seeing a shift in how day-to-day tasks are being performed. Artificial intelligence technology has opened the door for highly accurate auto-scoring solutions that will likely play a bigger role in AASM-accredited facilities in the future. While the U.S. [...]
SLEEP 2022, the 36th annual meeting of the Associated Professional Sleep Societies LLC (APSS), was held on June 4-8, 2022 in Charlotte, North Carolina. Since its inception in 1986, SLEEP has become the premier forum on sleep medicine. Each year, the APSS is proud [...]
On Nov. 12, the Food and Drug Administration issued a news release with updated findings related to the June recall of certain Philips Respironics ventilators and positive airway pressure machines due to potential health risks related to polyester-based polyurethane sound abatement foam used in [...]
On Sept. 1, Philips announced that it has received authorization from the Food and Drug Administration to “rework” the recalled first-generation DreamStation devices by replacing the sound abatement foam with a new material. Philips anticipates that the repair program will begin this month. The [...]
On June 30 the U.S. Food and Drug Administration (FDA) issued a safety communication in response to the voluntary recall by Philips of certain Philips Respironics bi-level positive airway pressure (BPAP), continuous positive airway pressure (CPAP), and mechanical ventilator devices due to potential health [...]
On June 14, Philips issued a recall notification for specific Philips bi-level positive airway pressure (bi-level PAP), continuous positive airway pressure (CPAP), and mechanical ventilator devices. The recall is in response to potential health risks related to the sound abatement foam component in these [...]
On Feb. 5, 2021, the FDA authorized marketing of a new prescription device, eXciteOSA (formerly Snoozeal), to reduce snoring and mild obstructive sleep apnea. It is the first device used while awake that is intended to improve tongue muscle function, which in time can [...]
On Nov. 23 the U.S. Food and Drug Administration authorized the emergency use of the ventilator accessory PortPatch, which is intended to reduce the spread of airborne particulates through the exhalation ports, anti-asphyxia valves, and carbon dioxide vents on full-face or non-rebreathing CPAP masks [...]
On Dec. 3 the U.S. Food and Drug Administration authorized the emergency use of the Lumin LM3000 device for bioburden reduction of compatible N95 respirators that are contaminated or potentially contaminated with SARS-CoV-2 or other pathogenic microorganisms. The Lumin LM3000 utilizes ultraviolet germicidal irradiation [...]
